Abstract
Background and importanceThe Canagliflozin Cardiovascular Assessment Study (CANVAS) indicated that use of sodium glucose cotransporter 2 inhibitors (SGLT2i) may increase the risk of fracture compared with placebo. However, the association...
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have